Terms: = Uterine cancer AND PDGFRB, JTK12, 5159, P09619, ENSG00000113721, PDGF-R-beta, PDGFR1, CD140B, PDGFR, CD140b
46 results:
1. Global expression analysis of endometrial cancer cells in response to progesterone identifies new therapeutic targets.
Thiel KW; Newtson AM; Devor EJ; Zhang Y; Malmrose PK; Bi J; Losh HA; Davies S; Smith LE; Padilla J; Leiva SM; Grueter CE; Breheny P; Hagan CR; Pufall MA; Gertz J; Guo Y; Leslie KK
J Steroid Biochem Mol Biol; 2023 Nov; 234():106399. PubMed ID: 37716459
[TBL] [Abstract] [Full Text] [Related]
2. High-Grade Sarcomas with Myogenic Differentiation Harboring Hotspot pdgfrb Mutations.
Dermawan JK; Chiang S; Hensley ML; Tap WD; Antonescu CR
Mod Pathol; 2023 May; 36(5):100104. PubMed ID: 36788091
[TBL] [Abstract] [Full Text] [Related]
3. Synergistic combination of ritonavir and cisplatin as an efficacious therapy in human cervical cancer cells: a computational drug discovery and
Swami D; Mudaliar P; Bichu YS; Kumar Sahu V; Devarajan S; Basu S; Aich J
J Biomol Struct Dyn; 2023; 41(12):5802-5816. PubMed ID: 35818867
[TBL] [Abstract] [Full Text] [Related]
4. Histopathologic and Molecular Characterization of uterine Leiomyoma-like Inflammatory Myofibroblastic Tumor: Comparison to Molecular Subtypes of uterine Leiomyoma.
Kuisma H; Jokinen V; Pasanen A; Heikinheimo O; Karhu A; Välimäki N; Aaltonen L; Bützow R
Am J Surg Pathol; 2022 Aug; 46(8):1126-1136. PubMed ID: 35426837
[TBL] [Abstract] [Full Text] [Related]
5. Novel Aspects of Genetics, Molecular Biology and Clinical Oncology of Sarcomas.
Houfková K; Hatina J
Klin Onkol; 2020; 33(1):66-78. PubMed ID: 32075391
[TBL] [Abstract] [Full Text] [Related]
6. uterine mesenchymal tumours: recent advances.
Momeni-Boroujeni A; Chiang S
Histopathology; 2020 Jan; 76(1):64-75. PubMed ID: 31846533
[TBL] [Abstract] [Full Text] [Related]
7. Placental site trophoblastic tumor and epithelioid trophoblastic tumor: Clinical and pathological features, prognostic variables and treatment strategy.
Gadducci A; Carinelli S; Guerrieri ME; Aletti GD
Gynecol Oncol; 2019 Jun; 153(3):684-693. PubMed ID: 31047719
[TBL] [Abstract] [Full Text] [Related]
8. Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the ETV6-NTRK3 fusion gene: a case report.
Takahashi A; Kurosawa M; Uemura M; Kitazawa J; Hayashi Y
J Int Med Res; 2018 Aug; 46(8):3498-3503. PubMed ID: 29900760
[TBL] [Abstract] [Full Text] [Related]
9. Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for uterine Leiomyosarcomas-an ENITEC Group Initiative.
Cuppens T; Annibali D; Coosemans A; Trovik J; Ter Haar N; Colas E; Garcia-Jimenez A; Van de Vijver K; Kruitwagen RP; Brinkhuis M; Zikan M; Dundr P; Huvila J; Carpén O; Haybaeck J; Moinfar F; Salvesen HB; Stukan M; Mestdagh C; Zweemer RP; Massuger LF; Mallmann MR; Wardelmann E; Mints M; Verbist G; Thomas D; Gommé E; Hermans E; Moerman P; Bosse T; Amant F
Clin Cancer Res; 2017 Mar; 23(5):1274-1285. PubMed ID: 28232476
[No Abstract] [Full Text] [Related]
10. Investigation of New Therapeutic Targets in Undifferentiated Endometrial Sarcoma.
Baek MH; Park JY; Rhim CC; Kim JH; Park Y; Kim KR; Nam JH
Gynecol Obstet Invest; 2017; 82(4):329-339. PubMed ID: 28125812
[TBL] [Abstract] [Full Text] [Related]
11. Systematic Analysis of Endometrial cancer-Associated Hub Proteins Based on Text Mining.
Gao H; Zhang Z
Biomed Res Int; 2015; 2015():615825. PubMed ID: 26366417
[TBL] [Abstract] [Full Text] [Related]
12. Second-line dovitinib (TKI258) in patients with FGFR2-mutated or FGFR2-non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage, phase 2 study.
Konecny GE; Finkler N; Garcia AA; Lorusso D; Lee PS; Rocconi RP; Fong PC; Squires M; Mishra K; Upalawanna A; Wang Y; Kristeleit R
Lancet Oncol; 2015 Jun; 16(6):686-94. PubMed ID: 25981814
[TBL] [Abstract] [Full Text] [Related]
13. A phase II evaluation of nintedanib (BIBF-1120) in the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study.
Dizon DS; Sill MW; Schilder JM; McGonigle KF; Rahman Z; Miller DS; Mutch DG; Leslie KK
Gynecol Oncol; 2014 Dec; 135(3):441-5. PubMed ID: 25312396
[TBL] [Abstract] [Full Text] [Related]
14. Fatal case of multiple recurrences of endometrial stromal sarcoma after fertility-sparing management.
Morimoto A; Tsubamoto H; Inoue K; Ikeda Y; Hirota S
J Obstet Gynaecol Res; 2015 Jan; 41(1):162-6. PubMed ID: 25163509
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic factors and status of hormone receptors and angiogenic factors in uterine carcinosarcoma.
Etoh T; Nakai H
J Obstet Gynaecol Res; 2014 Mar; 40(3):820-5. PubMed ID: 24320058
[TBL] [Abstract] [Full Text] [Related]
16. Normal and cancer stem cells of the human female reproductive system.
López J; Valdez-Morales FJ; Benítez-Bribiesca L; Cerbón M; Carrancá AG
Reprod Biol Endocrinol; 2013 Jun; 11():53. PubMed ID: 23782518
[TBL] [Abstract] [Full Text] [Related]
17. Endometrial stromal sarcoma: clinicopathological and immunophenotypic study of 16 cases.
Iwasaki S; Sudo T; Miwa M; Ukita M; Morimoto A; Tamada M; Ueno S; Wakahashi S; Yamaguchi S; Fujiwara K; Sakuma Y; Mikami Y; Nishimura R
Arch Gynecol Obstet; 2013 Aug; 288(2):385-91. PubMed ID: 23435725
[TBL] [Abstract] [Full Text] [Related]
18. uterine leiomyosarcoma management, outcome, and associated molecular biomarkers: a single institution's experience.
Lusby K; Savannah KB; Demicco EG; Zhang Y; Ghadimi MP; Young ED; Colombo C; Lam R; Dogan TE; Hornick JL; Lazar AJ; Hunt KK; Anderson ML; Creighton CJ; Lev D; Pollock RE
Ann Surg Oncol; 2013 Jul; 20(7):2364-72. PubMed ID: 23334251
[TBL] [Abstract] [Full Text] [Related]
19. Immunohistochemical analysis for therapeutic targets and prognostic markers in low-grade endometrial stromal sarcoma.
Park JY; Kim KR; Nam JH
Int J Gynecol Cancer; 2013 Jan; 23(1):81-9. PubMed ID: 23221606
[TBL] [Abstract] [Full Text] [Related]
20. Tyrosine kinase receptor status in endometrial stromal sarcoma: an immunohistochemical and genetic-molecular analysis.
Cossu-Rocca P; Contini M; Uras MG; Muroni MR; Pili F; Carru C; Bosincu L; Massarelli G; Nogales FF; De Miglio MR
Int J Gynecol Pathol; 2012 Nov; 31(6):570-9. PubMed ID: 23018215
[TBL] [Abstract] [Full Text] [Related]
[Next]
